{"id":"bw430c-lamotrigine","safety":{"commonSideEffects":[{"rate":"1-3","effect":"Rash (including Stevens-Johnson syndrome risk)"},{"rate":"10-15","effect":"Dizziness"},{"rate":"5-10","effect":"Ataxia"},{"rate":"5-10","effect":"Somnolence"},{"rate":"10-15","effect":"Headache"},{"rate":"5-10","effect":"Diplopia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lamotrigine stabilizes neuronal membranes by blocking sodium channels in a use-dependent manner, which prevents repetitive neuronal firing. It also inhibits the release of glutamate, an excitatory neurotransmitter, through effects on calcium channels. These combined actions reduce abnormal electrical activity in the brain.","oneSentence":"Lamotrigine blocks voltage-gated sodium channels and inhibits glutamate release, reducing neuronal excitability.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:04:36.103Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Epilepsy (adjunctive therapy for partial seizures)"},{"name":"Bipolar disorder (maintenance treatment of bipolar I disorder)"}]},"trialDetails":[{"nctId":"NCT06184581","phase":"PHASE4","title":"Lithium Versus Lamotrigine in Bipolar Disorder, Type II","status":"RECRUITING","sponsor":"University Hospital Bispebjerg and Frederiksberg","startDate":"2024-05-08","conditions":"Bipolar II Disorder","enrollment":200},{"nctId":"NCT06929273","phase":"PHASE3","title":"A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-07-18","conditions":"Bipolar Disorder Type I With Mania","enrollment":450},{"nctId":"NCT06729970","phase":"PHASE1","title":"A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants","status":"COMPLETED","sponsor":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","startDate":"2024-12-26","conditions":"Healthy Volunteers","enrollment":133},{"nctId":"NCT07140913","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-10-08","conditions":"Mania, Bipolar Disorder","enrollment":424},{"nctId":"NCT07413731","phase":"","title":"Neurophysiological Effects of Medication Tapering During Treatment With Spinal Cord Stimulation","status":"RECRUITING","sponsor":"Brai²n","startDate":"2025-02-03","conditions":"Persistent Spinal Pain Syndrome Type 2 (PSPS-T2), Lower Spine, Spinal Cord Sensitivity to Neurostimulation, Neurophysiological Sensitivity to Spinal Cord Stimulation","enrollment":50},{"nctId":"NCT05603104","phase":"PHASE3","title":"Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2025-04-27","conditions":"Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression","enrollment":1254},{"nctId":"NCT03196466","phase":"","title":"Population Pharmacokinetics of Antiepileptic in Pediatrics","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-19","conditions":"Epilepsy","enrollment":753},{"nctId":"NCT02670161","phase":"PHASE4","title":"Quality Improvement and Practice Based Research in Neurology Using the EMR","status":"ENROLLING_BY_INVITATION","sponsor":"Endeavor Health","startDate":"2016-05","conditions":"Brain Tumors, Epilepsy, Migraine","enrollment":3300},{"nctId":"NCT04274179","phase":"PHASE3","title":"Ketogenic Diet for New-Onset Absence Epilepsy","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2020-08-10","conditions":"Absence Epilepsy, Ketogenic Dieting, Epilepsy, Absence","enrollment":40},{"nctId":"NCT03689114","phase":"PHASE4","title":"Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2021-05-10","conditions":"Epilepsies, Partial","enrollment":58},{"nctId":"NCT04770493","phase":"PHASE2","title":"Enhancing the Effects of Alcohol Treatment With Lamotrigine","status":"COMPLETED","sponsor":"Brown University","startDate":"2022-01-24","conditions":"Alcohol Use Disorder","enrollment":44},{"nctId":"NCT03497143","phase":"","title":"Bariatric Surgery and Pharmacokinetics of Lamotrigine","status":"RECRUITING","sponsor":"Norwegian University of Science and Technology","startDate":"2016-11-02","conditions":"Obesity, Morbid","enrollment":12},{"nctId":"NCT05450978","phase":"","title":"Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2022-07-20","conditions":"Epilepsy, Pregnancy Related","enrollment":60},{"nctId":"NCT03774641","phase":"","title":"A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-12-03","conditions":"Bipolar Disorder, Major Depressive Disorder, Schizo Affective Disorder","enrollment":10},{"nctId":"NCT00838279","phase":"PHASE1","title":"Lamotrigine 25 mg Chewable Tablets, Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-02","conditions":"Healthy","enrollment":32},{"nctId":"NCT00838136","phase":"PHASE1","title":"Lamotrigine 25 mg Chewable Tablets, Non-Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-02","conditions":"Healthy","enrollment":32},{"nctId":"NCT00835263","phase":"PHASE1","title":"Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-01","conditions":"Healthy","enrollment":32},{"nctId":"NCT00834561","phase":"PHASE1","title":"Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-01","conditions":"Healthy","enrollment":32},{"nctId":"NCT05881928","phase":"PHASE4","title":"Effect of Adding Lamotrigine to Sodium Valproate in Childhood Epilepsy: Clinicolabratory Study","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-07-29","conditions":"Epilepsy, Lamotrigine, Sodium Valproate Adverse Reaction","enrollment":50},{"nctId":"NCT06488586","phase":"","title":"IV Ketamine Vs. in Esketamine for MDD TRD","status":"RECRUITING","sponsor":"Gustavo Vazquez","startDate":"2023-03-20","conditions":"Treatment Resistant Depression","enrollment":80},{"nctId":"NCT05708729","phase":"NA","title":"Neuromodulation for Central Post-stroke Pain: Mechanism, Safety and Outcome","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2023-01-24","conditions":"Central Post-stroke Pain, CPSP","enrollment":32},{"nctId":"NCT00647751","phase":"PHASE1","title":"Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2004-08","conditions":"Healthy","enrollment":28},{"nctId":"NCT00650208","phase":"PHASE1","title":"Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2004-07","conditions":"Healthy","enrollment":27},{"nctId":"NCT05450822","phase":"","title":"Precision Medicine in the Treatment of Epilepsy","status":"RECRUITING","sponsor":"Gitte Moos Knudsen","startDate":"2022-02-18","conditions":"Epilepsy","enrollment":550},{"nctId":"NCT05543122","phase":"","title":"Drug Concentrations in Breast Milk and Prediction of Blood Levels of the Breastfed Infants","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2022-03-09","conditions":"Breast Feeding","enrollment":39},{"nctId":"NCT04602221","phase":"PHASE1","title":"A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2020-12-01","conditions":"Healthy","enrollment":40},{"nctId":"NCT02893371","phase":"","title":"Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2016-09","conditions":"Bipolar Disorder","enrollment":1037352},{"nctId":"NCT06199791","phase":"PHASE1","title":"Single-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditions","status":"COMPLETED","sponsor":"Desitin Arzneimittel GmbH","startDate":"2023-04-03","conditions":"Fasting","enrollment":24},{"nctId":"NCT03504501","phase":"PHASE2","title":"Synaptic Plasticity and Cognitive Function in RASopathies","status":"TERMINATED","sponsor":"Technical University of Munich","startDate":"2019-03-22","conditions":"Impaired Synaptic Plasticity, Impaired Cognition","enrollment":16},{"nctId":"NCT00007670","phase":"PHASE3","title":"Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly.","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"1998-01","conditions":"Seizures","enrollment":720},{"nctId":"NCT05748236","phase":"PHASE4","title":"The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy","status":"UNKNOWN","sponsor":"Dhaka Medical College","startDate":"2022-11-01","conditions":"Focal Epilepsy","enrollment":70},{"nctId":"NCT00513019","phase":"PHASE2","title":"Double-Blind Lamictal (Lamotrigine) in Neurotic Excoriation","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2007-08","conditions":"Neurotic Excoriation, Pathologic Skin Picking, Psychogenic Excoriation","enrollment":35},{"nctId":"NCT05697614","phase":"PHASE4","title":"The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children","status":"UNKNOWN","sponsor":"Dr Cipto Mangunkusumo General Hospital","startDate":"2023-03-01","conditions":"Drug Resistant Epilepsy","enrollment":100},{"nctId":"NCT05639257","phase":"NA","title":"Treatment of Myotonia - Lamotrigine Versus Namuscla","status":"UNKNOWN","sponsor":"Grete Andersen, MD","startDate":"2022-12-05","conditions":"Non-Dystrophic Myotonia","enrollment":32},{"nctId":"NCT05017155","phase":"PHASE3","title":"MExiletine Versus Lamotrigine in Non-Dystrophic Myotonias","status":"UNKNOWN","sponsor":"University College, London","startDate":"2021-08-12","conditions":"Non-Dystrophic Myotonia","enrollment":60},{"nctId":"NCT01996293","phase":"","title":"Pregnant Women Taking Lamictal for Bipolar Disorder","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2013-09","conditions":"Bipolar Disorder","enrollment":30},{"nctId":"NCT04938856","phase":"PHASE1","title":"Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tablet Under Fasting Conditions","status":"COMPLETED","sponsor":"University of Karachi","startDate":"2020-09-04","conditions":"Bioequivalence","enrollment":26},{"nctId":"NCT01880957","phase":"NA","title":"PET and MRI Brain Imaging of Bipolar Disorder","status":"COMPLETED","sponsor":"Stony Brook University","startDate":"2011-11-08","conditions":"Bipolar Disorder, Bipolar Depression, Unipolar Depression","enrollment":76},{"nctId":"NCT05459597","phase":"","title":"Antiepileptic Drugs in Elderly Patients","status":"RECRUITING","sponsor":"Wei Zhao","startDate":"2021-01-01","conditions":"Seizure, Epileptic","enrollment":500},{"nctId":"NCT03636958","phase":"NA","title":"Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy","status":"WITHDRAWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2021-02-15","conditions":"Refractory Epilepsy","enrollment":""},{"nctId":"NCT02158585","phase":"PHASE2","title":"Study of Lamotrigine to Treat Ménière's Disease","status":"COMPLETED","sponsor":"Dent Neuroscience Research Center","startDate":"2014-06","conditions":"Meniere's Disease, Ménière's Vertigo, Vertigo, Intermittent","enrollment":15},{"nctId":"NCT05420350","phase":"PHASE2","title":"Lamotrigine and Bupropion for Meniere's Disease","status":"UNKNOWN","sponsor":"Dent Neuroscience Research Center","startDate":"2020-12-16","conditions":"Meniere Disease, Ménière's Vertigo, Vertigo, Intermittent","enrollment":34},{"nctId":"NCT02497443","phase":"PHASE1, PHASE2","title":"Safety of Autologous MSC Infusion to Treat Epilepsy","status":"COMPLETED","sponsor":"Ministry of Public Health, Republic of Belarus","startDate":"2011-04","conditions":"Epilepsy","enrollment":60},{"nctId":"NCT05236166","phase":"NA","title":"Multicentre Study on Rapid Versus Slow Withdrawal of Antiepileptic Monotherapy","status":"COMPLETED","sponsor":"University Magna Graecia","startDate":"2017-04-26","conditions":"Epilepsy","enrollment":48},{"nctId":"NCT05145608","phase":"PHASE1","title":"Comparative Bioavailability Study of Lamotrigine ER Tablets USP 50 mg","status":"COMPLETED","sponsor":"Alembic Pharmaceuticals Ltd.","startDate":"2018-01-10","conditions":"Bioequivalence","enrollment":22},{"nctId":"NCT04523935","phase":"PHASE4","title":"Excessive Crying in Children With Cerebral Palsy and Communication Deficits","status":"COMPLETED","sponsor":"Sathbhavana Brain Clinic","startDate":"2005-12-07","conditions":"Cerebral Palsy, Excessive Crying, Pain","enrollment":131},{"nctId":"NCT03161509","phase":"PHASE4","title":"Pharmacokinetics of Paracetamol and Antiepileptic Drugs After Sleeve Gastrectomy","status":"TERMINATED","sponsor":"Rambam Health Care Campus","startDate":"2017-07-01","conditions":"Bariatric Surgery Candidate","enrollment":2},{"nctId":"NCT04939675","phase":"NA","title":"Modification of Epilepsy Screen Questionnaire and Treatment Feasibility Evaluation","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2021-07-01","conditions":"Epilepsy","enrollment":40},{"nctId":"NCT03831854","phase":"PHASE3","title":"Lamotrigine in Reducing Psychologic Side-Effect of Perioperative Ketamine","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2019-01-24","conditions":"Reducing Psychological Side Effects of Ketamine","enrollment":46},{"nctId":"NCT04759196","phase":"PHASE4","title":"Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas","status":"UNKNOWN","sponsor":"Université de Sherbrooke","startDate":"2021-03-01","conditions":"Chronic Subdural Hematoma, Epilepsy; Seizure, Cortical Depression; Cortical Depolarization","enrollment":56},{"nctId":"NCT04156035","phase":"NA","title":"Ketamine-Induced Brain Changes and Their Modulation by Lamotrigine","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2020-03-10","conditions":"Emotions","enrollment":75},{"nctId":"NCT00483548","phase":"PHASE3","title":"Adjunctive Ziprasidone in the Treatment of Bipolar I Depression","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-10","conditions":"Bipolar Disorder, Depression, Bipolar","enrollment":298},{"nctId":"NCT00280059","phase":"PHASE3","title":"Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-08","conditions":"Epilepsy, Partial","enrollment":660},{"nctId":"NCT00855738","phase":"PHASE4","title":"A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-05","conditions":"Focal Epilepsy","enrollment":111},{"nctId":"NCT01995825","phase":"PHASE4","title":"Lamotrigine Bioequivalence","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2012-05","conditions":"Epilepsy","enrollment":35},{"nctId":"NCT00571246","phase":"PHASE3","title":"The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress Disorder","status":"WITHDRAWN","sponsor":"Yale University","startDate":"2012-06","conditions":"Alcohol Dependence, Post Traumatic Stress Disorder","enrollment":""},{"nctId":"NCT00618241","phase":"PHASE1","title":"Pharmacokinetic Study on Raltegravir and Lamotrigine","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2008-02","conditions":"HIV Infection","enrollment":24},{"nctId":"NCT00088452","phase":"PHASE3","title":"Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2004-07","conditions":"Childhood Absence Epilepsy, Petit Mal Epilepsy, Epilepsy","enrollment":453},{"nctId":"NCT01588457","phase":"PHASE4","title":"Sequential Multiple Assignment Treatment for Bipolar Disorder","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2011-06","conditions":"Bipolar I Disorder, Bipolar II Disorder","enrollment":112},{"nctId":"NCT02708849","phase":"PHASE1","title":"The Sustained Effects of Ketamine","status":"TERMINATED","sponsor":"Yale University","startDate":"2015-06","conditions":"Mental Disorders","enrollment":3},{"nctId":"NCT03116828","phase":"PHASE4","title":"A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2017-07-07","conditions":"Epilepsy With Partial On-set Seizures","enrollment":102},{"nctId":"NCT03695094","phase":"PHASE1","title":"A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil","status":"COMPLETED","sponsor":"UCB Biopharma S.P.R.L.","startDate":"2018-09-18","conditions":"Epilepsy","enrollment":31},{"nctId":"NCT04396938","phase":"NA","title":"The Effect of a Single Dose of Lamotrigine on Brain Function in Healthy Volunteers","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2017-05-10","conditions":"Healthy","enrollment":36},{"nctId":"NCT02821338","phase":"PHASE1","title":"A Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy Subjects","status":"COMPLETED","sponsor":"Food and Drug Administration (FDA)","startDate":"2016-06","conditions":"Healthy","enrollment":30},{"nctId":"NCT02256124","phase":"PHASE2, PHASE3","title":"Effect of Lamotrigine on Cognition in NF1","status":"TERMINATED","sponsor":"Erasmus Medical Center","startDate":"2014-10","conditions":"Neurofibromatosis Type 1","enrollment":41},{"nctId":"NCT02707965","phase":"PHASE1","title":"Characterization of Epilepsy Patients BEEP 2b","status":"COMPLETED","sponsor":"Food and Drug Administration (FDA)","startDate":"2017-06-08","conditions":"Epilepsy","enrollment":21},{"nctId":"NCT03419949","phase":"","title":"Comparison of Oral Lamotrigine Versus Pregabalin for Control of Acute and Chronic Pain","status":"AVAILABLE","sponsor":"Assiut University","startDate":"","conditions":"Acute and Chronic Pain Following Modified Radical Mastectomy","enrollment":""},{"nctId":"NCT01674010","phase":"PHASE2","title":"Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder","status":"TERMINATED","sponsor":"OPKO Health, Inc.","startDate":"2012-08","conditions":"Bipolar 1 Disorder","enrollment":309},{"nctId":"NCT04015687","phase":"PHASE1","title":"A Study to Evaluate the Effect of AG-881 on the Pharmacokinetics of a Single Dose of Lamotrigine in Healthy Adults","status":"COMPLETED","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2019-07-15","conditions":"Healthy Participants","enrollment":22},{"nctId":"NCT02404168","phase":"PHASE4","title":"BEEP Follow Up: Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic Patients","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2015-07-07","conditions":"Epilepsy","enrollment":4},{"nctId":"NCT00419003","phase":"PHASE4","title":"Research Study for Major Depressive Disorder: Investigation of Glutamate Medications","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2006-12","conditions":"Major Depression","enrollment":26},{"nctId":"NCT02428439","phase":"","title":"Identification of Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2015-04","conditions":"Depression, Suicidal Ideation","enrollment":80},{"nctId":"NCT02389712","phase":"PHASE4","title":"16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2015-03","conditions":"Bipolar Disorder","enrollment":2},{"nctId":"NCT03898011","phase":"PHASE1","title":"A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions","status":"COMPLETED","sponsor":"Pharmtechnology LLC","startDate":"2019-03-23","conditions":"Healthy Adults","enrollment":28},{"nctId":"NCT00223262","phase":"PHASE4","title":"Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2002-08","conditions":"Memory Impairment Due to Corticosteroid Use, Hypomania Due to Corticosteroid Use, Hippocampal Atrophy Due to Corticosteroid","enrollment":28},{"nctId":"NCT00404248","phase":"PHASE1, PHASE2","title":"Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2007-01","conditions":"Brain and Central Nervous System Tumors","enrollment":35},{"nctId":"NCT02989727","phase":"PHASE4","title":"Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine","status":"COMPLETED","sponsor":"University of Saskatchewan","startDate":"2003-11","conditions":"Depression, Bipolar Disorder, Bipolar Depression","enrollment":150},{"nctId":"NCT01015586","phase":"PHASE4","title":"Treatment of Alcohol Dependence and Comorbid Bipolar Disorder","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2010-02","conditions":"Alcohol Dependence, Bipolar Disorder, Depression","enrollment":43},{"nctId":"NCT00243152","phase":"NA","title":"Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI","status":"COMPLETED","sponsor":"Pain and Analgesia Imaging and Neuroscience Group","startDate":"2005-10","conditions":"Facial Neuropathy","enrollment":6},{"nctId":"NCT00612235","phase":"","title":"Premenstrual Dysphoric Disorder and Antiepileptic Drugs","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2008-04","conditions":"Epilepsy","enrollment":80},{"nctId":"NCT00916149","phase":"NA","title":"Cognitive Effects of Treatment of Interictal Discharges","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2007-01","conditions":"Epilepsy","enrollment":31},{"nctId":"NCT00395694","phase":"PHASE3","title":"Clinical Evaluation of BW430C in Epilepsy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-08-07","conditions":"Epilepsy","enrollment":102},{"nctId":"NCT01142310","phase":"PHASE4","title":"Reversing Corticosteroid Induced Memory Impairment","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2010-06","conditions":"Memory Impairment","enrollment":54},{"nctId":"NCT03338478","phase":"NA","title":"Balance and Anti-Epileptic Drugs","status":"COMPLETED","sponsor":"Erik J. Kobylarz","startDate":"2017-12-01","conditions":"Epilepsy","enrollment":42},{"nctId":"NCT02081287","phase":"PHASE1","title":"Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?","status":"COMPLETED","sponsor":"San Diego Veterans Healthcare System","startDate":"2014-05","conditions":"Bipolar Disorder, Manic Depression","enrollment":8},{"nctId":"NCT00068445","phase":"PHASE3","title":"Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2004-02","conditions":"Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":131},{"nctId":"NCT02374567","phase":"PHASE3","title":"Pharmacovigilance in Gerontopsychiatric Patients","status":"TERMINATED","sponsor":"Hannover Medical School","startDate":"2015-01","conditions":"Dementia, Depression, Schizophrenia","enrollment":407},{"nctId":"NCT02413918","phase":"PHASE4","title":"Iloperidone in Mixed States of Bipolar Disorder","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2012-04","conditions":"Bipolar Disorder","enrollment":41},{"nctId":"NCT02556060","phase":"PHASE2, PHASE3","title":"Lamotrigine for Ketamine Dependence Trial","status":"COMPLETED","sponsor":"Taipei City Hospital","startDate":"2015-09","conditions":"Addiction","enrollment":30},{"nctId":"NCT02100644","phase":"PHASE4","title":"Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-04-12","conditions":"Epilepsy","enrollment":33},{"nctId":"NCT00264680","phase":"","title":"Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-10-01","conditions":"Epilepsy","enrollment":333},{"nctId":"NCT00488566","phase":"PHASE1","title":"GSK Drug Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers","status":"COMPLETED","sponsor":"Biogen","startDate":"2007-05-31","conditions":"Bipolar Disorder","enrollment":50},{"nctId":"NCT00939614","phase":"PHASE1","title":"Study of Lamotrigine 2×25 mg IR Tablets of Torrent Pharmaceuticals Limited, India and Lamictal® (Lamotrigine) 2×25 mg Tablets of GlaxoSmithKline, USA, in Healthy Human Adult Subjects, Under Fasting Conditions.","status":"COMPLETED","sponsor":"Torrent Pharmaceuticals Limited","startDate":"","conditions":"Healthy","enrollment":""},{"nctId":"NCT00939458","phase":"PHASE1","title":"Study of Lamotrigine 2 x 25 mg IR Tablets of Torrent Pharmaceuticals Pvt., Ltd., India and Lamictal ® (Lamotrigine) 2 x 25 mg Tablets of Glaxo-SmithKline, USA, in Healthy Human Adult Subjects, Under Fed Conditions","status":"COMPLETED","sponsor":"Torrent Pharmaceuticals Limited","startDate":"","conditions":"Healthy","enrollment":""},{"nctId":"NCT00043914","phase":"PHASE4","title":"Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2002-01-14","conditions":"Epilepsy","enrollment":72},{"nctId":"NCT00144872","phase":"PHASE1","title":"LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2004-11-01","conditions":"Seizure, Absence","enrollment":54},{"nctId":"NCT01357902","phase":"PHASE1","title":"Lamotrigine Bioequivalence Study to Compare Dispersible Tables With Compressed Tablets in China","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-04-18","conditions":"Epilepsy","enrollment":24},{"nctId":"NCT01891890","phase":"PHASE3","title":"Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)","status":"TERMINATED","sponsor":"Emory University","startDate":"2013-08","conditions":"Epilepsy, Partial, Epilepsy, Localization Related","enrollment":72},{"nctId":"NCT00410371","phase":"PHASE1","title":"Study to Compare Two Formulations of Lamotrigine in Healthy Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-12-28","conditions":"Mental Disorders","enrollment":96},{"nctId":"NCT00605371","phase":"PHASE1","title":"Bioequivalence and Food Effect of 250mg of Lamotrigine XR","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-01-15","conditions":"Epilepsy","enrollment":209}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6818,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"BW430C (lamotrigine)","genericName":"BW430C (lamotrigine)","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lamotrigine blocks voltage-gated sodium channels and inhibits glutamate release, reducing neuronal excitability. Used for Epilepsy (adjunctive therapy for partial seizures), Bipolar disorder (maintenance treatment of bipolar I disorder).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}